Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

Flu Vaccines are now available for seniors and everyone ages 2 & up. Walk-ins accepted!
Covid-19 Vaccine and Covid-19 Bivalent Booster now available!
Please Click Here to schedule your appointment or call 310-204-1111.

Posted December 16, 2025

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”